Abstract
Currently, nuclear medicine imaging provides both functional/molecular and structural information, derived from a combination of different scientific techniques in radiochemical/radiopharmaceutical labeling, imaging technology, and image reconstruction methodologies as well as a good understanding of physiology and molecular biology and a sound approach to clinical interpretation. Pitfalls in nuclear medicine imaging fall into the following three main categories: (1) radioisotope or radiotracer; (2) scanning techniques, procedure, or scanner hardware or software; and (3) clinical, relating to patient factors and interpretation of scans. Various pitfalls from each category are described. Reducing artifacts arising from these three categories is key to the correct performance and interpretation of nuclear medicine studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- DTPA:
-
Diethylenetriaminepentaacetic acid
- ECG:
-
Electrocardiogram
- FDG:
-
F-18 fluorodeoxyglucose
- MAA:
-
Macroaggregated albumin
- MDP:
-
Methylene diphosphonate
- MIBG:
-
Metaiodobenzylguanidine
- MUGA:
-
Multi-gated acquisition
- PET:
-
Positron emission tomography
- PET-CT:
-
PET computed tomography
- PET-MRI:
-
PET magnetic resonance imaging
- SPECT:
-
Single-photon emission computed tomography
- SPECT-CT:
-
SPECT computed tomography
- SUV:
-
Standardized uptake value
- V/Q:
-
Ventilation-perfusion
References
Bamba Y, Itabashi M, Kameoka S (2011) Value of PET/CT imaging for diagnosing pulmonary metastasis of colorectal cancer. Hepatogastroenterology 58:1972–1974
Bomardieri E, Giammarile F, Aktolun C et al (2010) 131I/123I Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumor imaging. Eur J Nucl Med Mol Imaging 37:2436–2446
Bujenovic S, Mannting F, Chakrabarti R et al (2003) Artifactual 2-Deoxy-2-[18F]Fluoro-D-glucose localization surrounding metallic objects in a PET/CT scanner using CT-based attenuation correction. Mol Imaging Biol 5:20–22
Cohade C, Osman M, Nakamoto Y et al (2003) Initial experience with oral contrast in PET/CT: phantom and clinical studies. J Nucl Med 44:412–416
Corbett JR, Akinboboye OO, Bacharach SL et al (2006) Equilibrium radionuclide angiography. J Nucl Cardiol 13:e56–e79
Delbeke D, Coleman RE, Guiberteau MJ (2006) Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med 47:885–895
Gnanasegaran G, Cook G, Adamson K et al (2009) Patterns, variants, artifacts, and pitfalls in conventional radionuclide bone imaging and SPECT/CT. Semin Nucl Med 39:380–395
Goerres GW, Kamel E, Seifert B et al (2002) Accuracy of image coregistration of pulmonary lesions in patients with non-small cell lung cancer using an integrated PET/CT system. J Nucl Med 43:1469–1475
Guerra L, De Ponti E, Elisei F et al (2012) Respiratory gated PET/CT in a European multicentre retrospective study: added diagnostic value in detection and characterization of lung lesions. Eur J Nucl Med Mol Imaging 39:1381–1390
Hinton PJ, Clauss RP (2011) Dissociation of Tc-99m DTPA in a nebulizer. Nucl Med Comm 32:659–661
Kim SK, Kang KW, Lee JS et al (2006) Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer. Eur J Nucl Med Mol Imaging 33:148–155
Mayerhoefer ME, Prosch H, Herold CJ et al (2012) Assessment of pulmonary melanoma metastases with 18F-FDG PET/CT: which PET-negative patients require additional tests for definitive staging? Eur Radiol 22:2451–2457
Osman MM, Cohade C, Nakamoto Y et al (2003) Clinically significant inaccurate localization of lesions with PET/CT: frequency in 300 patients. J Nucl Med 44:240–243
Reinhardt MJ, Wiethoelter N, Matthies A et al (2006) PET recognition of pulmonary metastases on PET/CT imaging: impact of attenuation-corrected and non-attenuation corrected PET images. Eur J Nucl Med Mol Imaging 33:134–139
Schoder H, Erdi YE, Chao K et al (2004) Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients. J Nucl Med 45:559–566
Thie JA (2004) Understanding the standardized uptake value, its methods and implications for usage. J Nucl Med 45:1431–1434
van Dalen JA, Vogel WV, Corstens FH et al (2007) Multi-modality nuclear medicine imaging: artefacts, pitfalls and recommendations. Cancer Imaging 7:77–83
Yoshioka T, Yamaguchi K, Kubota K et al (2003) Evaluation of 18F-FDG PET in patients with advanced, metastatic or recurrent gastric cancer. J Nucl Med 44:690–699
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ng, D.C.E., Lam, W.W.C., Goh, A.S.W. (2015). Nuclear Medicine Imaging. In: Peh, W. (eds) Pitfalls in Diagnostic Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-44169-5_4
Download citation
DOI: https://doi.org/10.1007/978-3-662-44169-5_4
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-44168-8
Online ISBN: 978-3-662-44169-5
eBook Packages: MedicineMedicine (R0)